Clinical Study
Serum Vascular Endothelial Growth Factor Levels before and after Intravitreous Ranibizumab Injection for Retinopathy of Prematurity
Table 2
Serum VEGF levels in infants with ROP.
| Patient | Serum VEGF levels (pg/ml) | 1 day before IVR | 1 day after IVR | 3 days after IVR | 7 days after IVR |
| 1 | 391.57 | 12.75 | 15.97 | 22.41 | 2 | 149.77 | 7.91 | 9.52 | 17.58 | 3 | 238.80 | 12.75 | 15.97 | 72.09 | 4 | 185.86 | 22.41 | 9.52 | NA | 5 | 215.51 | 9.52 | 4.68 | 54.51 | 6 | 295.84 | NA | 25.63 | 28.85 | 7 | 350.75 | 15.97 | 12.75 | 41.69 | 8 | 337.08 | NA | 19.19 | 33.67 | 9 | 249.04 | 3.07 | 22.41 | 25.63 | 10 | 226.88 | 15.97 | 11.14 | 24.02 | 11 | 138.73 | 6.3 | 15.82 | 33.67 | 12 | 248.09 | 6.3 | 24.02 | 60.91 | 13 | 224.84 | 52.91 | 19.05 | NA | 14 | 210.84 | 31.94 | 48.11 | 48.04 | 15 | 130.84 | 41.69 | 15.97 | 12.59 | Median (IQR) | 226.9 (198.4, 272.4) | 12.8 (7.9, 22.4) | 16.0 (12.0, 20.8) | 33.7 (24.0, 48.0) |
|
|
NA: the serum VEGF level is not available because of the limited sample volumes.
|